Neuralstem, Inc. announced that safety results from the first 12 patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) to receive its stem cells were reported online in the peer-reviewed publication, STEM CELLS, on March 13th. "Lumbar Intraspinal Injection of Neural Stem Cells in Patients with ALS.
|
Scooped by
TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
onto #ALS AWARENESS #LouGehrigsDisease #PARKINSONS March 31, 2012 9:40 PM
|